Upgrades Archives - Page 9 of 188

1 minute read

Analyst Eyes Papa John’s Comparable Sales Amid Price-Value Concerns, Upgrades Stock To Hold

April 22, 1:29 PM

Stifel's Chris O'Cull shifts stance on Papa John's International to Hold, citing pragmatic near-term outlook. Despite lowering the price target to $60 amidst market turbulence, O'Cull emphasizes the stock's resilience. With -1% domestic comparable sales in Q1, challenges persist, particularly in a fiercely competitive market.

PZZA

1 minute read

Alcoa Makes ‘Solid Progress’ Addressing Operational Concerns, Analyst Is No Longer Bearish

By Priya Nigam

April 22, 11:49 AM

Alcoa Corp. reported Q1 results with a slight revenue beat. Morgan Stanley upgraded Alcoa's rating to Equal-Weight with a $36.50 target price. The company is making progress in cost saving measures and may benefit from IRA tax credits.

4 minute read

Netflix Stock Sized Up By 7 Analysts Post Q1 Results: ‘Pivot From A High-Growth, Low-Profit Business To A Slow-Growth, High-Profit Business’

By Chris Katje

April 19, 1:36 PM

Streaming leader Netflix reported first quarter financial results that were higher than estimates. The company's outlook and decision to stop reporting subscriber figures are weighing on analysts.

NFLX

1 minute read

Zoom Leverages ‘AI-Powered Advancements’ For Growth: Analyst Sees Market Edge

By Priya Nigam

April 18, 1:22 PM

Zoom Video Communications (ZM) is leading the AI trend, with successful partnerships and strong product momentum, according to an analyst.

AMZN

1 minute read

4 Reasons Why This Zscaler Analyst Is Turning Bullish: ‘Q1 Feedback Is Positive’

By Priya Nigam

April 18, 12:57 PM

Zscaler, considered a "Top Pick on the Zacks Analyst Blog," is a leader in the SASE (Secure Access Service Edge) market.

1 minute read

Election Impact: Analyst Eyes Potential Upside for Strategic Education with Republican Victory

By Shivani Kumaresan

Today, 1:48 PM

Truist Securities analyst boosts STRA's rating to Buy, citing robust enrollment prospects in U.S. adult education and potential margin gains from a high fixed-cost model. With a price target increase to $125, Sommer anticipates upward estimate revisions and potential multiple expansion, especially if Republicans reclaim the White House.

STRA

2 minute read

Avalo Therapeutics’ Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades

By Vandana Singh

Yesterday, 2:25 PM

Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction.

ABBV

2 minute read

Goldman Sachs Boasts ‘Near-Perfect’ Q1 Results, 5 Analysts Zero In On ‘Core Strengths’

By Priya Nigam

Yesterday, 12:09 PM

Goldman Sachs Group Inc (NYSE: GS) and other financial stocks have been in focus as some of the sector’s biggest banks report first-quarter results.

1 minute read

This CNO Financial Group Analyst Is Turning Bullish: Health, Life Products Exhibit ‘Consistent Profitability’

By Priya Nigam

Yesterday, 10:59 AM

CNO Financial Group Inc (NYSE: CNO) and other financial stocks have been in focus after some of the sector’s biggest banks reported first-quarter results.

CNO

2 minute read

Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA

By Vandana Singh

April 15, 2:42 PM

BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in 2023 to over $2 billion in 2025, Integer emerges as a key supplier for major PFA device manufacturers

BSX